DNA Expense Breakdown
Ginkgo Bioworks Holdings, Inc. (DNA). Quarter ended 2026-06-30 · each product line is listed as filed.
- 2026-06-30: Reportable $1.47M.
- 2025-06-30: Reportable $3.87M.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $1.47M |
| 2025-06-30 | $3.87M |
Depreciation, Depletion and Amortization, Nonproduction: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $12.31M |
| 2025-06-30 | $15.25M |
General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $11.11M |
| 2025-06-30 | $15.99M |
Research and development: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $30.43M |
| 2025-06-30 | $31.07M |